Integrating systems biology sources illuminates drug action

Area of Science:

• Pharmacogenomics
• Systems Biology
• Computational Biology

Background:

• Current understanding of drug action pathways is limited, hindering rational drug repurposing, side effect prediction, and drug interaction analysis.
• Mechanistic molecular insights are crucial for advancing precision medicine and optimizing therapeutic strategies.

Purpose of the Study:

• To introduce DrugRouter, a novel computational method for generating drug-specific pathways of action.
• To leverage gene interaction networks to link drug targets, disease genes, and pharmacogenes.

Main Methods:

• DrugRouter constructs pathways by integrating information from gene interaction networks, literature co-occurrence, and genome-wide association studies (GWAS).
• Pathways were generated for over one hundred drugs, linking target genes, disease genes, and pharmacogenes.
• Validation involved assessing pathway gene co-occurrence in literature and overlap/adjacency with known drug-response pathways and GWAS hits.

Main Results:

• Generated drug-specific pathways for numerous drugs, demonstrating their biological relevance through literature and genetic data.
• Validated pathway genes show significant overlap or adjacency with established drug-response pathways and GWAS findings related to drug response.
• The computed pathways successfully suggested novel drug-repositioning opportunities, such as using statins for follicular thyroid cancer.

Conclusions:

• DrugRouter provides a systems biology approach to generate hypotheses about drug actions and mechanisms of action.
• The method facilitates novel drug repositioning, identification of gene-side effect associations, and prediction of gene-drug interactions.
• This work enhances our ability to rationally utilize mechanistic molecular information for drug discovery and development.